| Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures D Lavanchy Journal of viral hepatitis 11 (2), 97-107, 2004 | 3213 | 2004 |
| The global burden of hepatitis C D Lavanchy Liver international 29, 74-81, 2009 | 1702 | 2009 |
| Evolving epidemiology of hepatitis C virus D Lavanchy Clinical Microbiology and Infection 17 (2), 107-115, 2011 | 1527 | 2011 |
| The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt C Frank, MK Mohamed, GT Strickland, D Lavanchy, RR Arthur, ... The Lancet 355 (9207), 887-891, 2000 | 1368 | 2000 |
| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The Lancet Gastroenterology & Hepatology 2 (3), 161-176, 2017 | 748 | 2017 |
| EASL international consensus conference on hepatitis B 13-14 September, 2002 Geneva, Switzerland Consensus statement (Long version) R De Franchis, A Hadengue, G Lau, D Lavanchy, A Lok, N McIntyre, ... Journal of Hepatology 39 (SUPPL. 1), 2003 | 656* | 2003 |
| EASL international consensus conference on hepatitis B 13-14 September, 2002 Geneva, Switzerland Consensus statement (Long version) R De Franchis, A Hadengue, G Lau, D Lavanchy, A Lok, N McIntyre, ... Journal of Hepatology 39 (SUPPL. 1), 2003 | 656* | 2003 |
| Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention D Lavanchy Journal of clinical virology 34, S1-S3, 2005 | 632 | 2005 |
| EASL international consensus conference on hepatitis B 13-14 September, 2002 Geneva, Switzerland Consensus statement (Long version) R De Franchis, A Hadengue, G Lau, D Lavanchy, A Lok, N McIntyre, ... Journal of Hepatology 39 (SUPPL. 1), 2003 | 523 | 2003 |
| EASL international consensus conference on hepatitis B 13-14 September, 2002 Geneva, Switzerland Consensus statement (Long version) R De Franchis, A Hadengue, G Lau, D Lavanchy, A Lok, N McIntyre, ... Journal of Hepatology 39 (SUPPL. 1), 2003 | 523 | 2003 |
| Global burden of disease (GBD) for hepatitis C Global Burden of Hepatitis C Working Group The Journal of Clinical Pharmacology 44 (1), 20-29, 2004 | 429 | 2004 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 415 | 2014 |
| Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium World Health Organization J Viral Hepat 6, 35-47, 1999 | 337 | 1999 |
| Historical epidemiology of hepatitis C virus (HCV) in selected countries P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ... Journal of viral hepatitis 21, 5-33, 2014 | 296 | 2014 |
| Strategies to manage hepatitis C virus (HCV) disease burden H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ... Journal of viral hepatitis 21, 60-89, 2014 | 213 | 2014 |
| Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants D FitzSimons, G François, A Hall, B McMahon, A Meheus, A Zanetti, ... Vaccine 23 (32), 4158-4166, 2005 | 162 | 2005 |
| WHO report on global surveillance of epidemic-prone infectious diseases World Health Organization World Health Organization, 2000 | 161 | 2000 |
| EASL international consensus conference on hepatitis B. 13–14 September, 2002: Geneva, Switzerland. Consensus statement (short version) E Jury J Hepatol 38 (4), 533-540, 2003 | 156 | 2003 |
| Chronic viral hepatitis as a public health issue in the world D Lavanchy Best practice & research Clinical gastroenterology 22 (6), 991-1008, 2008 | 135 | 2008 |
| Seroprevalence of hepatitis E virus in Switzerland D Lavanchy, B Morel, PC Frei The Lancet 344 (8924), 747-748, 1994 | 133 | 1994 |
